Alaunos Therapeutics

TCRT • NASDAQ • Stock Fundamentals

Alaunos Therapeutics is a biotechnology company in the healthcare sector trading on NASDAQ, led by CEO Holger Weis, with a market cap of $5.4M.

Market Cap$5.4M

Employees34.0

CEOHolger Weis

CountryUnited States of America

Healthcare

Biotechnology

Most Recent EarningsMay 15, 2026 · 0 months 30 days agoQ1 2026

Next EarningsAug 18, 2026 · in 2 monthsQ2 2026

Financials

Based on Q1 2026 filing

Common questions about Alaunos Therapeutics

Alaunos Therapeutics (TCRT) has a market capitalization of $5.4M and trades on NASDAQ.

Alaunos Therapeutics has approximately 34 employees.